These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24551084)

  • 41. Effect of mechanochemical inclusion of triamterene into sulfobutylether-β-cyclodextrin and its improved dissolution behavior.
    Maeda H; Shiobara R; Tanaka M; Kajinami A; Nakayama H
    Drug Dev Ind Pharm; 2021 Apr; 47(4):535-541. PubMed ID: 33185132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A; Londhe V
    Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrin.
    Shanmuga Priya A; Sivakamavalli J; Vaseeharan B; Stalin T
    Int J Biol Macromol; 2013 Nov; 62():472-80. PubMed ID: 24076034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced dissolution, stability and physicochemical characterization of ATRA/2-hydroxypropyl-β-cyclodextrin inclusion complex pellets prepared by fluid-bed coating technique.
    Chen Z; Lu Y; Qi J; Wu W
    Pharm Dev Technol; 2013 Feb; 18(1):130-6. PubMed ID: 22304703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of preparation processes and structural insight into the supermolecular system: Bisacodyl and β-cyclodextrin inclusion complex.
    Li S; Zhai Y; Yan J; Wang L; Xu K; Li H
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():224-32. PubMed ID: 26478306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A supramolecular complex between proteinases and beta-cyclodextrin that preserves enzymatic activity: physicochemical characterization.
    Denadai AM; Santoro MM; Lopes MT; Chenna A; de Sousa FB; Avelar GM; Gomes MR; Guzman F; Salas CE; Sinisterra RD
    BioDrugs; 2006; 20(5):283-91. PubMed ID: 17025375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
    Jambhekar S; Casella R; Maher T
    Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity.
    Paczkowska-Walendowska M; Rosiak N; Tykarska E; Michalska K; Płazińska A; Płaziński W; Szymanowska D; Cielecka-Piontek J
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
    Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
    Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
    Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L
    Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
    Nekkanti V; Karatgi P; Paruchuri S; Pillai R
    Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
    Sinha VR; Anitha R; Ghosh S; Amita ; Kumria R; Bhinge JR; Kumar M
    Acta Pharm; 2007 Mar; 57(1):47-60. PubMed ID: 19839406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation, Characterization, and Properties of Inclusion Complexes of Balofloxacin with Cyclodextrins.
    Ren X; Qian H; Tang P; Tang Y; Liu Y; Pu H; Zhang M; Zhao L; Li H
    AAPS PharmSciTech; 2019 Aug; 20(7):278. PubMed ID: 31396732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
    Zhang YM; Li X; Sun CS; Chen CF
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar; 28(3):711-4. PubMed ID: 18536450
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
    Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
    AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Removing Control of Cyclodextrin-Drug Complexes Using High Affinity Molecule.
    Kim YH; Kim ST; Jee JP; Kim DY; Kang D; Kim K; Park SY; Sim T; Cho KH; Jang DJ
    J Nanosci Nanotechnol; 2018 Feb; 18(2):898-901. PubMed ID: 29448513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
    Jain AS; Date AA; Pissurlenkar RR; Coutinho EC; Nagarsenker MS
    AAPS PharmSciTech; 2011 Dec; 12(4):1163-75. PubMed ID: 21918921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.